Humana
$379.68Change from previous close: −0.50%Absolute change: −$1.89
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $45.59B
- Enterprise value
- $36.53B
- P/E (trailing 12 months)
- 35.9
- Forward P/E
- 22.9
- PEG
- 1.28
- Price/book
- 2.37
- Price/sales
- 0.31
- EV/EBITDA
- 10.2
- EV/revenue
- 0.25
Profitability and growth
- Gross margin
- 13.7%
- Operating margin
- 3.5%
- Net margin
- 0.9%
- ROE
- 6.9%
- ROA
- 3.9%
- Revenue growth (year over year)
- 26.2%
- Earnings growth (year over year)
- 27.1%
Financial health
- Total cash
- $23.87B
- Total debt
- $14.74B
- Debt/equity
- 0.76
- Current ratio
- 1.74
- Quick ratio
- 1.29
Dividends
- Annual dividend per share
- $3.54
- Dividend yield
- 0.9%
- Payout ratio
- 33.5%
- Ex-dividend date
- October 30, 2026
Analysts and estimates
- Average price target
- $423.74
- Median price target
- $420.00
- High price target
- $515.00
- Low price target
- $280.00
- Analysts with a price target
- 23
- Consensus
- Buy
- Forward EPS
- $16.57
- EPS estimate, current year
- $9.15
Shares and trading
- Beta
- 0.75
- Average volume
- 1.21M
- Shares outstanding
- 120.08M
- Float
- 119.82M
- Institutional ownership
- 100.9%
- Insider ownership
- 0.2%
- Short interest (% of float)
- 2.7%
- Short ratio (days)
- 3.03